BB-101 (Blue Blood Biotech/National Cheng Kung University)

N/A

Report date: 2024/05/16 16:36:33

Base Information

Drug NameBB-101 (Blue Blood Biotech/National Cheng Kung University)
Drug Alias NamerhNEGFBB-101
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Cheng Kung UniversityBlue Blood Biotech Corp
China Registration ClassN/A

Develop Information

Active CompaniesBlue Blood Biotech Corp
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A